Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry Methods

The objective of this study was to evaluate the value of molecular methods in the management of community-acquired pneumonia (CAP) in children. Previously developed mass spectrometry (MS)-based methods combined with quantitative real-time PCR (combined-MS methods) were used to describe the aetiology...

Full description

Bibliographic Details
Main Authors: Liying Sun, Chi Zhang, Shuhua An, Xiangpeng Chen, Yamei Li, Leshan Xiu, Baoping Xu, Zhengde Xie, Junping Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.695134/full
_version_ 1818872433703124992
author Liying Sun
Liying Sun
Chi Zhang
Chi Zhang
Shuhua An
Xiangpeng Chen
Yamei Li
Yamei Li
Leshan Xiu
Leshan Xiu
Baoping Xu
Zhengde Xie
Junping Peng
Junping Peng
author_facet Liying Sun
Liying Sun
Chi Zhang
Chi Zhang
Shuhua An
Xiangpeng Chen
Yamei Li
Yamei Li
Leshan Xiu
Leshan Xiu
Baoping Xu
Zhengde Xie
Junping Peng
Junping Peng
author_sort Liying Sun
collection DOAJ
description The objective of this study was to evaluate the value of molecular methods in the management of community-acquired pneumonia (CAP) in children. Previously developed mass spectrometry (MS)-based methods combined with quantitative real-time PCR (combined-MS methods) were used to describe the aetiology and evaluate antibiotic therapy in the enrolled children. Sputum collected from 302 children hospitalized with CAP were analyzed using the combined-MS methods, which can detect 19 viruses and 12 bacteria related to CAP. Based on the results, appropriate antibiotics were determined using national guidelines and compared with the initial empirical therapies. Respiratory pathogens were identified in 84.4% of the patients (255/302). Co-infection was the predominant infection pattern (51.7%, 156/302) and was primarily a bacterial-viral mixed infection (36.8%, 111/302). Compared with that using culture-based methods, the identification rate for bacteria using the combined-MS methods (61.8%, 126/204) increased by 28.5% (p <0.001). Based on the results of the combined-MS methods, the initial antibiotic treatment of 235 patients was not optimal, which mostly required switching to β-lactam/β-lactamase inhibitor combinations or reducing unnecessary macrolide treatments. Moreover, using the combined-MS methods to guide antibiotic therapy showed potential to decrease the length of stay in children with severe CAP. For children with CAP, quantitative molecular testing on sputum can serve as an important complement to traditional culture methods. Early aetiology elucidated using molecular testing can help guide the antibiotic therapy.
first_indexed 2024-12-19T12:38:44Z
format Article
id doaj.art-ea2e57a7a42b4ba5998fc443c3768ee0
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-12-19T12:38:44Z
publishDate 2021-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-ea2e57a7a42b4ba5998fc443c3768ee02022-12-21T20:21:04ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882021-07-011110.3389/fcimb.2021.695134695134Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry MethodsLiying Sun0Liying Sun1Chi Zhang2Chi Zhang3Shuhua An4Xiangpeng Chen5Yamei Li6Yamei Li7Leshan Xiu8Leshan Xiu9Baoping Xu10Zhengde Xie11Junping Peng12Junping Peng13NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, ChinaKey Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, ChinaKey Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Respiratory Medicine, Hebei Children’s Hospital, Hebei Medical University, Shijiazhuang, ChinaBeijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, Research Unit of Critical Infection in Children, Chinese Academy of Medical Sciences, 2019RU016, Laboratory of Infection and Virology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, ChinaNHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, ChinaKey Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, ChinaKey Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNational Clinical Research Center for Respiratory Diseases, Research Unit of Critical Infection in Children, Chinese Academy of Medical Sciences, 2019RU016, Respiratory Department, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, ChinaBeijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, Research Unit of Critical Infection in Children, Chinese Academy of Medical Sciences, 2019RU016, Laboratory of Infection and Virology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, ChinaNHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, ChinaKey Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaThe objective of this study was to evaluate the value of molecular methods in the management of community-acquired pneumonia (CAP) in children. Previously developed mass spectrometry (MS)-based methods combined with quantitative real-time PCR (combined-MS methods) were used to describe the aetiology and evaluate antibiotic therapy in the enrolled children. Sputum collected from 302 children hospitalized with CAP were analyzed using the combined-MS methods, which can detect 19 viruses and 12 bacteria related to CAP. Based on the results, appropriate antibiotics were determined using national guidelines and compared with the initial empirical therapies. Respiratory pathogens were identified in 84.4% of the patients (255/302). Co-infection was the predominant infection pattern (51.7%, 156/302) and was primarily a bacterial-viral mixed infection (36.8%, 111/302). Compared with that using culture-based methods, the identification rate for bacteria using the combined-MS methods (61.8%, 126/204) increased by 28.5% (p <0.001). Based on the results of the combined-MS methods, the initial antibiotic treatment of 235 patients was not optimal, which mostly required switching to β-lactam/β-lactamase inhibitor combinations or reducing unnecessary macrolide treatments. Moreover, using the combined-MS methods to guide antibiotic therapy showed potential to decrease the length of stay in children with severe CAP. For children with CAP, quantitative molecular testing on sputum can serve as an important complement to traditional culture methods. Early aetiology elucidated using molecular testing can help guide the antibiotic therapy.https://www.frontiersin.org/articles/10.3389/fcimb.2021.695134/fullcommunity-acquired pneumoniarespiratory pathogensmolecular testingmass spectrometryantibiotic therapy
spellingShingle Liying Sun
Liying Sun
Chi Zhang
Chi Zhang
Shuhua An
Xiangpeng Chen
Yamei Li
Yamei Li
Leshan Xiu
Leshan Xiu
Baoping Xu
Zhengde Xie
Junping Peng
Junping Peng
Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry Methods
Frontiers in Cellular and Infection Microbiology
community-acquired pneumonia
respiratory pathogens
molecular testing
mass spectrometry
antibiotic therapy
title Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry Methods
title_full Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry Methods
title_fullStr Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry Methods
title_full_unstemmed Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry Methods
title_short Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry Methods
title_sort comprehensive description of pathogens and antibiotic treatment guidance in children with community acquired pneumonia using combined mass spectrometry methods
topic community-acquired pneumonia
respiratory pathogens
molecular testing
mass spectrometry
antibiotic therapy
url https://www.frontiersin.org/articles/10.3389/fcimb.2021.695134/full
work_keys_str_mv AT liyingsun comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods
AT liyingsun comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods
AT chizhang comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods
AT chizhang comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods
AT shuhuaan comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods
AT xiangpengchen comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods
AT yameili comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods
AT yameili comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods
AT leshanxiu comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods
AT leshanxiu comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods
AT baopingxu comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods
AT zhengdexie comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods
AT junpingpeng comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods
AT junpingpeng comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods